Medtronic (MDT) Free Cash Flow (2014 - 2026)

Medtronic (MDT) has 13 years of Free Cash Flow data on file, last reported at $2.1 billion in Q2 2026.

• For the quarter ending Q2 2026, Free Cash Flow rose 0.77% year-over-year to $2.1 billion; the trailing twelve-month figure through Apr 2026 stood at $5.4 billion (up 4.65% YoY), and the FY2026 full-year result was $5.4 billion, up 4.65% from the prior year.
• Free Cash Flow retreated to $2.1 billion in Q2 2026, from $2.3 billion in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $2.4 billion in Q2 2024 to a low of $200.0 million in Q4 2023.
• A 5-year average of $1.3 billion and a median of $1.5 billion in 2022 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow sank 66.61% in 2023 and soared 177.0% in 2024, its largest moves.
• Tracing MDT's Free Cash Flow over 5 years: stood at $599.0 million in 2022, then slumped by 66.61% to $200.0 million in 2023, then soared by 177.0% to $554.0 million in 2024, then dropped by 17.51% to $457.0 million in 2025, then jumped by 356.24% to $2.1 billion in 2026.
• Business Quant data shows MDT's Free Cash Flow at $2.1 billion in Q2 2026, $2.3 billion in Q1 2026, and $457.0 million in Q4 2025.